Back
ATAI Life Sciences NV Quote, Financials, Valuation and Earnings
Sponsored
ATAI
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
38
ATAI
ATAI Life Sciences NV
Last Price:
1.09
Seasonality Move:
-7.19%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeATAI Life Sciences NV Price Quote
$1.09
+0.01 (+0.93%)
(Updated: November 5, 2024 at 5:14 AM ET)
ATAI Life Sciences NV Key Stats
Sell
38
ATAI Life Sciences NV (ATAI)
is a Sell
Day range:
$1.08 - $1.13
52-week range:
$1.03 - $2.85
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.08%
Volume:
596.5K
Avg. volume:
661.7K
1-year change:
-17.8%
Market cap:
$182.1M
Revenue:
$314K
EPS:
$-0.39
How Much Does ATAI Life Sciences NV Make?
Data Unavailable
Is ATAI Life Sciences NV Growing As A Company?
-
What Is ATAI Life Sciences NV's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.59% -
What Is ATAI Life Sciences NV's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
ATAI Life Sciences NV Stock Price Performance
-
Did ATAI Life Sciences NV Stock Go Up Last Month?
ATAI Life Sciences NV share price went down by -6.47% last month -
Did ATAI's Share Price Rise Over The Last Year?
ATAI share price fell by -17.8% over the past 1 year
What Is ATAI Life Sciences NV 52-Week High & Low?
-
What Is ATAI Life Sciences NV’s 52-Week High Share Price?
ATAI Life Sciences NV has traded as high as $2.85 over the past 52 weeks -
What Is ATAI Life Sciences NV’s 52-Week Low Share Price?
ATAI Life Sciences NV has traded as low as $1.03 over the past 52 weeks
ATAI Life Sciences NV Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy ATAI Life Sciences NV?
-
How Much Debt Does ATAI Life Sciences NV Have?
Total long term debt quarterly is $18.6M -
How Much Cash Does ATAI Life Sciences NV Have?
Cash and short term investments quarterly total is $88.3M -
What Is ATAI Life Sciences NV’s Book Value Per Share?
Book value per share is 1.00
Is ATAI Life Sciences NV Cash Flow Positive?
-
What Is ATAI Cash Flow From Operations?
Cash flow from operations (TTM) is -$79.2M -
What Is ATAI Life Sciences NV’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$8.1M -
What Is ATAI Life Sciences NV’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$19.5M
ATAI Life Sciences NV Return On Invested Capital
-
Is Management Doing A Good Job?
ATAI return on invested capital is -24.06% -
What Is ATAI Life Sciences NV Return On Assets?
ROA measures how assets are converting to revenues and is -21.67% -
What Is ATAI Return On Equity?
ROE is a measure of profitability and is -25.92%
ATAI Life Sciences NV Earnings Date & Stock Price
-
What Is ATAI Life Sciences NV's Stock Price Today?
A single share of ATAI can be purchased today for 1.09 -
What Is ATAI Life Sciences NV’s Stock Symbol?
ATAI Life Sciences NV trades on the nasdaq under the ticker symbol: ATAI -
When Is ATAI Life Sciences NV’s Next Earnings Date?
The next quarterly earnings date for ATAI Life Sciences NV is scheduled on November 14, 2024 -
When Is ATAI's next ex-dividend date?
ATAI Life Sciences NV's next ex-dividend date is November 5, 2024 -
How To Buy ATAI Life Sciences NV Stock?
You can buy ATAI Life Sciences NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ATAI Life Sciences NV Competitors
-
Who Are ATAI Life Sciences NV's Competitors?
Below is a list of companies who compete with ATAI Life Sciences NV or are related in some way:
ATAI Life Sciences NV Dividend Yield
-
What Is ATAI Dividend Yield?
ATAI Life Sciences NV’s dividend yield currently is 0% -
What Is ATAI Life Sciences NV’s Payout Ratio?
ATAI Life Sciences NV’s payout ratio is 0% -
When Did ATAI Life Sciences NV Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is ATAI Life Sciences NV’s Dividend Per Share?
ATAI Life Sciences NV pays a dividend of $0.00 per share
ATAI Life Sciences NV Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -129.78% |
Revenue: | 58.72% | 0% |
Analyst Recommendations
Buy Recommendations: | 4 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 9.25 |
Upside from Last Price: | 752.53% |